WuXi Biologics

2025.09.05

16:10

Hong Kong Stock Market Close Review: Hang Seng Index rose 1.43%, Hang Seng Tech Index rose 1.95%

At the close of Hong Kong trading, the Hang Seng Index rose 1.43%, while the Hang Seng Tech Index rose 1.95%. The Hong Kong Tech ETF (159751) rose 2.5%, and the Hang Seng Hong Kong Stock Connect ETF (159318) rose 1.54%. Among sectors, biotechnology and semiconductor products and equipment led the gains. In terms of individual stocks, Horizon Robotics-W rose 9.12%, Kelun Botai Bio-B rose 6.63%, China Biologic Products rose 6.2%, China Aluminum Corporation rose 6.12%, Hengrui Medicine rose 5.96%, Shandong Gold rose 5.87%, Zijin Mining rose 5.85%, Luoyang Molybdenum Co., Ltd. rose 5.77%, China Hongqiao rose 5.14%, Kangfang Biopharmaceuticals rose 5.09%, SMIC rose 4.82%, WuXi Biologics rose 4.71%, Hansoh Pharmaceutical rose 4.56%, Zhaojin Mining rose 4.44%, Kuaishou-W rose 4.36%, WuXi AppTec rose 4.22%; Gemdale Properties fell 4.49%, Uni-President Enterprises China fell 4.62%; China Innovation Aviation rose 18.37%, and Sansure Pharmaceutical rose 18.24%.

12:02

Hong Kong Stock Market Midday Review: Hang Seng Index rose 0.62%, Hang Seng Tech Index rose 0.82%

At the midday close of Hong Kong stocks, the Hang Seng Index rose 0.62%, and the Hang Seng Tech Index rose 0.82%. The Hong Kong Tech ETF (159751) rose 1.16%, and the Hang Seng Hong Kong Stock Connect ETF (159318) rose 0.59%. Among sectors, biotechnology and aerospace & defense saw the largest gains. Among individual stocks, Horizon Robotics-W rose 7.79%, Kelun Biotech-B rose 5.51%, Zijin Mining rose 5.25%, Sino Biopharmaceutical rose 5.24%, WuXi Biologics rose 4.65%, Akeso Biopharmaceuticals rose 4.14%, and SMIC rose 4.02%. Uni-President Enterprises China fell 3.23%, Crown Watch & Jewelry fell 3.28%, Mobvista rose 12.9%, and China New Aviation rose 12.38%.

2025.09.02

09:57

Hong Kong-listed biopharmaceutical stocks collectively strengthened, with BeiGene (06160.HK) rising more than 6%, Tiger Pharmaceuticals (03347.HK) and WuXi Biologics (02268.HK) rising more than 3%, and WuXi Biologics (02269.HK) and WuXi AppTec (02359.HK) rising more than 2%.

09:52

Hong Kong-listed innovative drug stocks surged in early trading, with BeiGene rising over 6%.

Hong Kong-listed innovative drug concept stocks rose rapidly in early trading, with BeiGene rising more than 6%, Corning Life Sciences rising more than 5%, WuXi Biologics, Innovent Biologics, and CStone Pharmaceuticals all rising.

2025.09.01

16:10

Hong Kong Stock Market Close: Hang Seng Index rose 2.15%, Hang Seng Tech Index rose 2.2%, Alibaba-W rose 18.5%

At the close of Hong Kong trading, the Hang Seng Index rose 2.15%, while the Hang Seng Tech Index rose 2.2%. The Hong Kong Tech ETF (159751) rose 1.75%, and the Hang Seng Hong Kong Stock Connect ETF (159318) rose 1.53%. Among sectors, metals & mining and hotel & resort REITs led the gains, while aerospace & defense and leisure equipment & supplies led the declines. In terms of individual stocks, Alibaba-W rose 18.5%, Alibaba-WR rose 18.08%, CSPC Pharmaceutical Group rose 9.14%, Innovent Biologics rose 8.83%, WuXi Biologics rose 8.37%, Zijin Mining rose 7.74%, WuXi AppTec rose 7.51%, Kelun Biotech-B rose 7.0%, Shandong Gold rose 6.95%, Luoyang Molybdenum Co., Ltd. rose 6.73%, BOC (Hong Kong) rose 6.7%, BOC (Hong Kong)-R rose 6.27%, Sinopharm rose 6.17%, BeiGene rose 5.59%, SMIC rose 4.86%, NIO-SW rose 4.64%, Smoore International rose 4.39%, Hengrui Medicine rose 4.33%; Minth Group fell 7.91%, Meitu fell 13.88%; MicroPort Medical rose 21.96%.

13:07

Hong Kong stocks of innovative drug concepts continued to strengthen in the afternoon, with Innovent Biologics (01801.HK) rising more than 8%, Jingtai Holdings (02228.HK) rising more than 7%, WuXi Biologics (02269.HK) and WuXi AppTec (02359.HK) rising nearly 7%, and CSPC Pharmaceutical Group (01093.HK) rising nearly 6%.

12:02

Hong Kong Stock Market Midday Review: Hang Seng Index rose 1.77%, Hang Seng Tech Index rose 1.77%

At the midday close of Hong Kong stocks, the Hang Seng Index rose 1.77%, while the Hang Seng Tech Index rose 1.77%. The Hong Kong Tech ETF (159751) rose 1.67%, and the Hang Seng Hong Kong Stock Connect ETF (159318) rose 1.09%. Among sectors, healthcare technology and pharmaceuticals led the gains, while aerospace & defense and leisure equipment & supplies led the declines. In terms of individual stocks, Alibaba-W rose 17.29%, Alibaba-WR rose 16.67%, Innovent Biologics rose 9.04%, BOC (Hong Kong) rose 6.08%, BOC (Hong Kong)-R rose 6.03%, Zijin Mining rose 5.86%, WuXi Biologics rose 5.84%, WuXi AppTec rose 5.84%, Shandong Gold rose 5.79%, Smoore International rose 5.61%, CSPC Pharmaceutical Group rose 5.07%, SMIC rose 4.94%, Kelun Biotech-B rose 4.71%, BeiGene rose 4.45%, and ZTE rose 4.23%; BYD Co., Ltd. fell 6.82%, Meitu fell 12.18%; Melco International Development rose 18.76%.

10:08

Hong Kong's Hang Seng Index rose 2%, while Alibaba's stock price rose by more than 17%.

Hong Kong's Hang Seng Index saw gains extend to 2%, with the Hang Seng Tech Index now up 1.95%. Alibaba-W surged over 17%, WuXi Biologics rose over 5%, while SMIC and Baidu Group rose over 3%.

10:04

Most of the Hong Kong stocks in the innovative drug sector rose, with WuXi Biologics (02269.HK) rising more than 5%, WuXi AppTec (02359.HK) rising more than 4%, BeiGene (06160.HK) and CSPC Pharmaceutical Group (01093.HK) rising nearly 4%.

2025.08.29

16:12

At the close of Hong Kong stocks, the Hang Seng Index closed up 0.32%, and the S&P 500 Index closed up 0.54%; BYD Electronics (00285.HK) rose more than 7%, WuXi Biologics (02269.HK), CSPC Pharmaceutical Group (01093.HK), WuXi AppTec (02359.HK), and Horizon Robotics (09660.HK) all rose more than 5%, while Hua Hong Semiconductor (01347.HK) fell nearly 6%.

16:12

Hong Kong Stock Market Close Review: Hang Seng Index rose 0.32%, Hang Seng Tech Index rose 0.54%

At the close of Hong Kong trading, the Hang Seng Index rose 0.32%, while the Hang Seng Tech Index rose 0.54%. The Hong Kong Tech ETF (159751) rose 0.62%, and the Hang Seng Hong Kong Stock Connect ETF (159318) rose 0.15%. Among sectors, home furnishings and electrical equipment led the gains, while aerospace & defense and water utilities saw the largest declines. In terms of individual stocks, Coastal Home rose by more than 160%; WuXi Biologics rose by 6.96%, Innovent Biologics rose by 6.84%, Shijiazhuang Pharmaceutical Group rose by 6.67%, WuXi AppTec rose by 6.51%, China Biologic Products rose by 5.46%, Horizon Robotics-W rose by 5.38%, Haitian Flavoring rose by 5.27%, Hengrui Medicine rose by 4.89%, Ctrip Group-S rose by 4.71%, Haier Smart Home rose by 4.62%, CATL rose by 4.17%, and Li Auto-W rose by 4.03%; SF Holding fell by 11.62%, and SJM Holdings fell by 13.17%; Guangzhou-Shenzhen Railway Co., Ltd. rose by 18.04%, and Guotai Junan International rose by 15.69%.

13:15

Hong Kong-listed pharmaceutical outsourcing concept stocks rose again in the afternoon. Via Biotech (01873.HK) rose more than 17%, WuXi Biologics (02269.HK) rose more than 8.5%, Zhaoyan Pharmaceutical (06127.HK) and WuXi AppTec (02359.HK) both rose more than 7%, and CStone Pharmaceuticals (06821.HK) and Corning Life Sciences (03759.HK) both rose more than 4%.

12:02

Hong Kong Stock Market Midday Review: Hang Seng Index rose 0.63%, Hang Seng Tech Index rose 0.56%

At the midday close of Hong Kong stocks, the Hang Seng Index rose 0.63%, and the Hang Seng Tech Index rose 0.56%. The Hong Kong Tech ETF (159751) rose 0.35%, while the Hang Seng Hong Kong Stock Connect ETF (159318) fell 0.07%. Among sectors, biotechnology and electrical equipment led the gains, while aerospace & defense and passenger airlines led the declines. In terms of individual stocks, CATL rose 7.12%, Innovent Biologics rose 6.89%, WuXi Biologics rose 6.64%, Haier Smart Home rose 6.62%, CSPC Pharmaceutical Group rose 6.36%, China Biologic Products rose 6.24%, Ctrip Group-S rose 5.16%, Luoyang Molybdenum Co., Ltd. rose 4.66%, Zijin Mining Co., Ltd. rose 4.62%, Horizon Robotics-W rose 4.5%, Li Auto-W rose 4.42%, BeiGene rose 4.29%; China Taiping Insurance fell 12.19%, and SJM Holdings fell 13.47%; Guangzhou-Shenzhen Railway Co., Ltd. rose 18.56%, and Guotai Junan International rose 15.29%.

10:52

Hong Kong-listed biopharmaceutical stocks rebounded sharply, with Rongchang Biopharma (09995.HK) rising more than 9.5%, WuXi Biologics (02269.HK) rising more than 7.5%, WuXi Associates (02268.HK) rising more than 6%, WuXi AppTec (02359.HK) and Junshi Biosciences (01877.HK) both rising more than 5%, followed by Conoya (02162.HK) and Fuhong Hanlin (02696.HK).

10:31

Hong Kong-listed innovative drug stocks continued to rise, with Hebo Pharmaceutical rising nearly 10%.

Hong Kong-listed innovative drug concept stocks continued to rise, with Hebo Pharmaceutical-B rising nearly 10%, Rongchang Biopharma rising more than 8%, WuXi Biologics rising more than 6%, Zhaoyan Pharmaceutical, Junshi Biosciences, and Innovent Biologics all rising.

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Qualcomm (QCOM.O) CEO: Qualcomm needs more energy-efficient chips.
                            2025-09-06

                                    Jefferies: Raised Alibaba (BABA.N) price target from $150.00 to $165.00.
                            2025-09-01

                                    The statement showed that Alibaba and Bosch announced the deepening of their strategic partnership.
                            2025-09-02

                                    The value of projects signed at the 2025 Smart Expo exceeds 200 billion yuan
                            2025-09-05

                                    Challenger Gray, a US employment consulting firm, reports that pharmaceutical companies announced plans to lay off 19,112 employees in August, bringing the total to 22,433. This represents a 142% increase compared to the 9,254 layoffs reported in the same period last year. The industry is facing increasing competition from patent expirations and is refocusing on higher-margin products. Many companies are also implementing artificial intelligence, which is leading to restructuring and job losses.
                            2025-09-04